These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2. Bodin S; Previti S; Jestin E; Vimont D; Ait-Arsa I; Lamare F; Rémond E; Hindié E; Cavelier F; Morgat C ACS Omega; 2023 Feb; 8(7):6994-7004. PubMed ID: 36844603 [TBL] [Abstract][Full Text] [Related]
25. The partial agonist properties of levocabastine in neurotensin-induced analgesia. Dubuc I; Remande S; Costentin J Eur J Pharmacol; 1999 Sep; 381(1):9-12. PubMed ID: 10528128 [TBL] [Abstract][Full Text] [Related]
26. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911 [TBL] [Abstract][Full Text] [Related]
27. Differential sensitivity to neurotensin-induced hypothermia, but not analgesia, in Fischer and Lewis rats. Bauco P; Rompré PP Peptides; 2003 Aug; 24(8):1189-94. PubMed ID: 14612190 [TBL] [Abstract][Full Text] [Related]
28. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals. Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421 [TBL] [Abstract][Full Text] [Related]
29. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice. Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268 [TBL] [Abstract][Full Text] [Related]
30. Time course of the hypothermic response to continuously administered neurotensin. Popp E; Schneider A; Vogel P; Teschendorf P; Böttiger BW Neuropeptides; 2007 Oct; 41(5):349-54. PubMed ID: 17655926 [TBL] [Abstract][Full Text] [Related]
31. Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. Boules M; McMahon B; Warrington L; Stewart J; Jackson J; Fauq A; McCormick D; Richelson E Brain Res; 2001 Nov; 919(1):1-11. PubMed ID: 11689157 [TBL] [Abstract][Full Text] [Related]
32. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats. Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285 [TBL] [Abstract][Full Text] [Related]
33. Comparison of some biological properties of neurotensin and its natural analogue LANT-6. Kitabgi P; Checler F; Vincent JP Eur J Pharmacol; 1984 Apr; 99(4):357-60. PubMed ID: 6329790 [TBL] [Abstract][Full Text] [Related]
34. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. Pettibone DJ; Hess JF; Hey PJ; Jacobson MA; Leviten M; Lis EV; Mallorga PJ; Pascarella DM; Snyder MA; Williams JB; Zeng Z J Pharmacol Exp Ther; 2002 Jan; 300(1):305-13. PubMed ID: 11752130 [TBL] [Abstract][Full Text] [Related]
35. Characterization of beta-lactotensin, a bioactive peptide derived from bovine beta-lactoglobulin, as a neurotensin agonist. Yamauchi R; Usui H; Yunden J; Takenaka Y; Tani F; Yoshikawa M Biosci Biotechnol Biochem; 2003 Apr; 67(4):940-3. PubMed ID: 12784648 [TBL] [Abstract][Full Text] [Related]
36. Antinociceptive effect induced by a combination of opioid and neurotensin moieties vs. their hybrid peptide [Ile(9)]PK20 in an acute pain treatment in rodents. Kleczkowska P; Hermans E; Kosson P; Kowalczyk A; Lesniak A; Pawlik K; Bojnik E; Benyhe S; Nowicka B; Bujalska-Zadrozny M; Misicka A; Lipkowski AW Brain Res; 2016 Oct; 1648(Pt A):172-180. PubMed ID: 27473894 [TBL] [Abstract][Full Text] [Related]
37. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation. Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F Eur J Pharmacol; 1997 Sep; 334(1):49-53. PubMed ID: 9346327 [TBL] [Abstract][Full Text] [Related]
38. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action. Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089 [TBL] [Abstract][Full Text] [Related]
39. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling. Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993 [TBL] [Abstract][Full Text] [Related]
40. Biological activity of neurotensin and its C-terminal partial sequences. Kataoka K; Taniguchi A; Shimizu H; Soda K; Okuno S; Yajima H; Kitagawa K Brain Res Bull; 1978; 3(5):555-7. PubMed ID: 122721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]